Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 2/20 | 0.36 |
| ▸ | MTOR | P42345 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 9/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | NAMPT | P43490 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21847682 | 0.86 | PIK3CA (0.38) | PIK3CAMTORESR2MEN1KMT2A | |
| SCHEMBL21847679 | 0.81 | ESR2 (0.40) | PIK3CAMTORESR2MEN1KMT2A | |
| SCHEMBL22169245 | 0.80 | ELANE (0.32) | PIK3CAMTORESR2MEN1KMT2A | |
| SCHEMBL21847688 | 0.79 | PIK3CA (0.40) | PIK3CAMTORESR2MEN1KMT2A | |
| SCHEMBL29226277 | 0.78 | PIK3CA (0.39) | PIK3CAMTORESR2MEN1KMT2A | |
| SCHEMBL22169255 | 0.77 | ESR2 (0.44) | PIK3CAMTORESR2NR1H2HDAC1 | |
| SCHEMBL29226367 | 0.76 | PIK3CA (0.38) | PIK3CAMTORESR2MEN1KMT2A | |
| SCHEMBL23554273 | 0.75 | NR1H2 (0.41) | PIK3CAMTORESR2MEN1KMT2A | |
| SCHEMBL21847643 | 0.72 | MAPK1 (0.45) | PIK3CAMTORNAMPT | |
| SCHEMBL15758320 | 0.70 | PDK1 (0.37) | ESR2MEN1KMT2ANR1H2ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10604519-B2 | 5,7-dihydro-pyrrolo-pyridine derivatives | PFIZER INC. (US) | 2020-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10604519-B2 | 5,7-dihydro-pyrrolo-pyridine derivatives | CHRM1, CHRM5, CHRM2 | PIK3CA 1793/4885MTOR 2801/4885ESR2 1598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.